Christoph Petry

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Peter Dubsky, Jan C. Brase, R. Jakesz et al. · British Journal of Cancer · 2013 · 349 citations · Full text

Medicine, Endocrinology, Oncology +17

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Peter Dubsky, Martin Filipits, R. Jakesz et al. · Annals of Oncology · 2012 · 216 citations

Medicine, Endocrinology, Oncology +17

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Richard Buus, Ivana Šestak, Ralf Kronenwett et al. · JNCI Journal of the National Cancer Institute · 2016 · 209 citations · Full text

Medicine, Biostatistics, Oncology +17

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

Miguel Martín, Jan C. Brase, Lourdes Calvo et al. · Breast Cancer Research · 2014 · 164 citations · Full text

Medicine, Endocrinology, Oncology +16

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Juanita Lopez, Thomas Powles, Fadi Braiteh et al. · Nature Medicine · 2025 · 96 citations · Full text

Medicine, Oncology, Pharmacology +8